Addressing Optic Neuritis, Neuromyelitis Optica and Multiple Sclerosis

By promoting neuroprotection and remyelination

Promoting Neuroprotection

First-in-class SGK agonists for rare ophthalmological conditions


first-in-class small molecules promoting neuroprotection and remyelination.
Read more


Rare ophthalmological conditions: optic neuritis and neuromyelitis optica.
Read more


Convocatoria de Junta General Extraordinaria de la Sociedad Bionure Farma, S.L. - Notice of the General Meeting of Shareholders of Bionure Farma, S.L.